Connect with us

Business

CV Sciences Inc (OTCMKTS:CVSI) Reports Fourth Quarter And Full Year 2017 Financial Results

Published

on

CV Sciences Inc

CV Sciences Inc (OTCMKTS:CVSI) has announced its financial results for the fourth quarter and year ended December 31, 2017.

The company reported sales of $7.2 million and $20.7 million for the fourth quarter and full year respectively. This demonstrates the company’s organic growth and expansion of sales channels. Of the channels that have boosted the company’s sales include wholesale, natural product retails and direct-to-consumer.

The natural product retail channel currently has over 1,500 locations spread throughout the country. The company is now working on opening and developing new sales channels, a move that is highly motivated by the impressive performance of its branded products like SPINS® Scan data.  These products have positioned the company as the leader in selling hemp product line in the natural products industry.

The company reported gross profit of $5.2 million for the fourth quarter and $14.5 million for the full year. This affirms the company’s ability and potential to increase sales while at the same time maintaining strong gross margins.

The company’s Adjusted EBITDA for the full year amounted to $2.1 million, which is an indication of strong operating leverage from the investment that the company is making in product development, inventory, systems, distribution and marketing.

While commenting on the results, CV Sciences CFO Joseph Dowling said that the company closed the year with a lot of momentum by reaching record highs for the fourth quarter as well as impressive results for the full year.  He added that the company’s financial performance shows its ability to generate cash flow and grow its profits. Dowling noted that the company recorded new performance records in all aspects and established a strong foundation for continued growth of profits.  He added that the company continues to make a lot of progress in drug development.  CV Sciences is currently advancing the development of CVSI-007, the company’s proprietary lead drug candidate.

At the close of the financial year, the company had $2,013,000 in unrestricted cash and total cash amounting to $2,792,000. During the year, the company increased its cash position to$1,734,000. Additionally, shareholders cash amounted to around $16.4 million at the end of the year.

*Past performance is not a predictor of future results. All investing involves risk of loss and individual investments may vary. The examples provided may not be representative of typical results. Your capital is at risk when you invest – you can lose some or all of your money. Never risk more than you can afford to lose.By submitting your information you agree to the terms of our Privacy Policy • Cancel Newsletter Any Time.This is a FREE service from Finacials Trend. Signing up for our FREE daily e-letter also entitles you to receive this report. We will NOT share your email address with anyone.

FEATURED STORIES

PROFILES1 month ago

Post Views: 33,909 Can you spot the difference between the hemp plant and marijuana plant? Hint: It’s not in the...

Business2 months ago

Stem Holdings Inc (OTCMKTS:STMH) Reports A Growth Of 960% In Q3 2020: Unveils TJGardens Branded Tinctures

Post Views: 774 Stem Holdings Inc (OTCMKTS:STMH) posted an increase of 960% YoY to $6.7 million in Q3 2020. It...

Business2 months ago

Indiva Ltd (OTCMKTS:NDVAF) Signs Three Provincial Agreements: Expands Distribution Network To Eight Provinces: Reports A Robust Growth Of 1273.7% In Q2 2020 Revenues

Post Views: 694 Indiva Ltd (OTCMKTS:NDVAF) posted a robust growth of 1273.7% YoY to CAD 2.826 million in revenues in...

Business2 months ago

4Front Ventures Corp (OTCMKTS:FFNTF) Receives Approval From CCC For Mission Dispensary and Cultivation Facilities In Worcester: Will Commence Adult-Use Cannabis Sales

Post Views: 743 CCC (Cannabis Control Commission) in Massachusetts approved cultivation and processing facilities and Mission Dispensary of 4Front Ventures...

Business2 months ago

Pure Sunfarms, A Joint Venture Of Village Farms International Inc (NASDAQ:VFF), Ships Bottled Oil Products TO British Columbia

Post Views: 821 Pure Sunfarms, which is a Village Farms International Inc (NASDAQ:VFF) JV, commenced shipment of Cannabis 2.0 products...

INDUSTRIAL HEMP2 months ago

Health Canada Grants Cannabis 2.0 License To Abba Medix Corp, An Auxiliary Of Canada House Cannabis Group Inc (OTCMKTS:SARSF)

Post Views: 671 Abba Medix Corp., a wholly-owned subsidiary of Canada House Cannabis Group Inc (OTCMKTS:SARSF), received an amended cannabis...